Home › Funds › Palo Alto Investors LP › CTNM
Palo Alto Investors LP position in CTNM
CONTINEUM THERAPEUTICS INC · Health Care
Palo Alto Investors LP reported holding 220,226 shares of CTNM (CONTINEUM THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.44% of its reported portfolio and ranking #31 among its reported holdings. Palo Alto Investors LP first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Palo Alto Investors LP's CTNM position evolved
Palo Alto Investors LP first disclosed a stake in CTNM in Q3 2026 at 220,226 shares (US$3.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 220.23K | $2.96M | New |
About CTNM and 13F data
CTNM (CONTINEUM THERAPEUTICS INC) is a Health Care company. 54 other funds we track also report a position in CTNM — the largest reported positions include MONTANOVA CAPITAL, LLC (US$37.8M), JOHNSON & JOHNSON (US$26.6M), Trails Edge Capital Partners, LP (US$22.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CTNM
- MONTANOVA CAPITAL, LLC 2.81M sh · $37.77M · Q3 2026
- JOHNSON & JOHNSON 1.98M sh · $26.56M · Q3 2026
- Trails Edge Capital Partners, LP 1.69M sh · $22.73M · Q3 2026
- Versant Venture Management, LLC 1.29M sh · $17.35M · Q3 2026
- Novo Holdings A/S 704.01K sh · $9.45M · Q3 2026
- SECTORAL ASSET MANAGEMENT INC 689.59K sh · $9.25M · Q3 2026
- Hillhouse Capital (HHLR Advisors) 669.34K sh · $8.98M · Q3 2026
- Red Tree Management, LLC 638.16K sh · $8.56M · Q3 2026
- Boxer Capital Management, LLC 494.00K sh · $6.63M · Q3 2026
- Ikarian Capital, LLC 300.00K sh · $4.03M · Q3 2026
- Squadron Capital Management LLC 225.00K sh · $3.02M · Q3 2026
- HighVista Strategies LLC 217.79K sh · $2.92M · Q3 2026
More on Palo Alto Investors LP
FAQ
How long has Palo Alto Investors LP held CTNM?
Palo Alto Investors LP has disclosed CTNM holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Palo Alto Investors LP's current position in CTNM?
As of Q3 2026, Palo Alto Investors LP holds 220.23K shares of CTNM (CONTINEUM THERAPEUTICS INC), valued at $2.96M, representing 0.44% of its reported portfolio and ranking #31.
Has Palo Alto Investors LP been buying or selling CTNM?
In the latest 13F filing (Q3 2026), Palo Alto Investors LP newly opened its position in CTNM.
Which other funds hold CTNM?
Other major institutional holders of CTNM include MONTANOVA CAPITAL, LLC, JOHNSON & JOHNSON, Trails Edge Capital Partners, LP, among 54 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.